Your Dedicated Oncology, Rare Disease & Complex Trials CRO in the U.S. and Globally
Deep Scientific Expertise
Ergomed Clinical Research is a leading Contract Research Organization (CRO) with a team of experienced scientists and industry experts who offer unparalleled knowledge and innovative approaches to clinical research. Our deep understanding of regulatory landscapes, cutting-edge technology, and data-driven methodologies allows us to deliver customized solutions that expedite the development and approval of safe and effective therapies.
Patient-Centric Clinical Trials
At Ergomed CRO, our commitment to patient-centric solutions is deeply rooted in our origins as practicing physicians. A shared mission drives our team to make a difference. We actively collaborate with advocacy groups, caregivers, and trusted physicians to understand the patient journey better. This collaborative approach enables us to expedite the delivery of life-changing medicines to more patients faster, underscoring our patient-centric focus.
Ergomed CARE™ is not just another clinical trial support system. Our proprietary, innovative approach seamlessly supports patients, investigators, and clinical sites throughout the trial. This unique service, Ergomed CARE™, is a testament to our commitment to improving patient enrollment, satisfaction, and retention, setting us apart from other CROs.
We are global oncology and orphan drug development leaders backed by 25 years of experience. We provide high-quality, innovative clinical research services and solutions tailored to the needs of even the most complex clinical trials.
Therapeutic Expertise
Complex Clinical Trials
Clinical trials are increasingly complex due to expanding regulatory requirements, especially in drug development for novel treatments such as cell and gene therapies, oncolytic viruses, biologics, and personalized medicines. Our experts excel in planning and executing complex trials involving vulnerable populations, including children and those with rare diseases.
Therapeutic Expertise
Rare Disease
Rare disease often involves advanced therapeutic products and pediatric patients, each raising the complexity and challenges of trials. We know how to deliver trials with small populations and highly advanced therapeutics, offering hope for patients with rare diseases and their families.
Therapeutic Expertise
Oncology Clinical Trials Solutions
We understand the nuances and complexities of oncology trials and how to ensure the setup maximizes future success. Ergomed’s complete solution for oncology trials delivers genuine expertise and robust processes to provide excellence in execution.
Why Ergomed?
Our tailored, comprehensive, high-quality clinical research services and solutions support even the most complex clinical trials.
We Are Invested in Your Success with Customized Site Support
Patient-Focused Oncology, Rare Disease, & Complex Trials CRO
Highly Skilled Staff, Driven by Science
Strong U.S. Presence
US-based Biotechnology Company
Ergomed is a trusted partner. Our past experience taught us that they are highly competent and motivated. Their enrolment was fast and the study was clean.”
European Pharmaceutical Company
Ergomed has always treated our projects with care, and the conduct of the study is unheard of in this industry. Balancing what is required and what is nice has not always been straightforward, with many parties involved. The Ergomed team has always tried to have our best interest at heart, which I appreciated.”
US-based Biotechnology Company
I appreciate everyone’s tremendous efforts. It’s so exciting to have dosed the first patient in Europe—big achievement, and the start of a strong European presence for sure!”
US-based Pharmaceutical Company
Ergomed’s study team members’ commitment and dedication have enabled the start of this phase and we greatly appreciate all your efforts.”
European Biotechnology Company
Appreciated recruitment ahead of schedule and collaborative approach across the organization – highlighting Ergomed transparency.”
US-based Biotechnology Company
Shout out to Ergomed’s Regulatory Affairs and Feasibility teams for their excellent communication and thorough, proactive support. They’ve been instrumental in driving feasibility efforts and ensuring clear, reliable regulatory guidance.”
Discover Our Latest Insights
Access Ergomed's resources for the latest in clinical trial trends and innovations.